Navigation Links
Retinal Acuity Meter, RAM

ProductsRetinal Acuity Meter, RAM
Company AMA Optics, Inc.
Item Retinal Acuity Meter, RAM
Features 
Description The Retinal Acuity Meter (RAM) is the first visual examination device that is clinically proven to accurately predict RETINAL ACUITY in eyes with glaucoma, cataract, and macular disease. The RAM is hand-held, battery operated, and can test each eye easily in under 60 seconds. Manufactured by AMA Optics, Inc. and tested at Columbia University in New York City, the RAM can help determine if unexplained vision loss is due to maculopathy or cataract, and thus prevent costly and time-consuming testing. Delays in cataract surgery can be avoided when retinal acuity tests better than anticipated, and during the exam, the RAM makes it possible for patients to visualize the letter clarity prior to the procedure and give them realistic post-surgical expectations.

Prediction of post-operative acuity has been documented prior to cataract removal to within two lines in 98% of eyes, and within one line in 97% of eyes prior to YAG laser capsulotomy when preoperative acuity is better than 20/200. The RAM can also accurately measure potential visual acuity in patients with glaucomatous changes, and in eyes with clear media, can quickly measure acuity without formal refraction.

The RAM technology is a combination of three basic optical principles: small aperture pinhole, correct visual angle, and bright illumination. The small aperture pinhole places the eye is almost universal focus and near correction is added to maximize resolution. Multiple pinholes allow the patient to select the clearest view through the cloudy media. The letters at 40 cm subtend the same visual angle as Snellen letters at 20 feet. The bright illumination more than compensates for the reduced illumination by the small aperture pinhole and the media opacity.
Info AMA Optics, Inc.
Customer Service: (887) 744-3937
Web site: http://www.amaoptics.com/

Related medicine products :

1. Gass Retinal Detachment Hook
2. Olk Angled Retinal Pick - 110 Degree
3. Olk Angled Retinal Pick - 150 Degree
4. Olk Angled Retinal Pick - 130 Degree
5. Weiss Retinal Pick 90 Degree Long
6. Weiss Retinal Pick 120 Degree Long
7. Weiss Retinal Pick 120 Degree Short
8. Weiss Retinal Pick 90 Degree Short
9. Olk Angled Retinal Spatula - 110 Degree
10. Olk Angled Retinal Spatula - 150 Degree
11. Olk Angled Retinal Spatula - 130 Degree
... experience, the SSD-1000 is a high performance ... our advanced technologies and over 5 decades ... technology as our more expensive systems, the ... compact and mobile setting., We also employ ...
... CONMED's family of products allows you to ... generators feature proprietary Energy Synchronous Processing Technology. ... current and voltage in all operational modes. ... to sample current and voltage over 450,000 ...
The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...
... and Tissue Adhesive is a formulation of ... mussel). These proteins are the key components ... to anchor itself to solid substrates in ... Tissue Adhesive is used to attach cells ...
Medicine Products:
(Date:10/31/2014)... October 31, 2014 At the start ... families narrowly escaping carbon monoxide poisoning in their homes. ... weeks away, one family-owned, Missouri-based heating and cooling company ... making sure families start the home heating season with ... secure. , Beginning Nov. 1, 2014, E and ...
(Date:10/31/2014)... -- Surgery for low back pain caused by spinal ... you live, a new report says. "Nearly 80 ... some point in their lives, and about 30 million ... spine problem," co-author Brook Martin, of the Dartmouth Institute ... college news release. In spinal stenosis, thickening of ...
(Date:10/31/2014)... DARIEN, IL – New research suggests that insomnia is ... crashes and other unintentional fatal injuries. The results underscore ... of the National Healthy Sleep Awareness Project. , Results ... in a dose-dependent manner with the number of insomnia ... were 2.8 times more likely to die from a ...
(Date:10/31/2014)... October 31, 2014 The Suspension Revolution ... workout program was developed by Dan Long, a suspension ... as a fitness professional and life coach. The author ... having toned muscles is not impossible , The Suspension ... suspension training. Suspension training promises efficiency when it comes ...
(Date:10/31/2014)... 31, 2014 Florida Air Academy, ... girls in grades 6-12, is taking the lead ... injuries and concussions, becoming the first high school ... (Immediate Post-Concussion Assessment and Cognitive Testing) computerized assessment ... Player' lawsuit grabs the headlines, and the Centers ...
Breaking Medicine News(10 mins):Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3
... byproduct even showed protection for women, study finds, , , ... byproduct that some research has linked to certain cancers, ... and may even offer slight protection for women, new ... than 120,000 men and women, Dutch researchers reported that ...
... of the American Academy of Disaster Medicine,s (AADM), Gary ... from a disaster medicine perspective on the recent swine ... why improvements are needed to the U.S. public health ... or pathogen; how disaster medicine specialists are helping other ...
... In conjunction with DURECT Corporation,s (Nasdaq: DRRX ... invited to listen to the conference call that will be ... at 4:30 pm Eastern Time (1:30 pm Pacific Time).A live ... DURECT,s homepage at http://www.durect.com ...
... In the wake of media reports on the outbreak ... services company, is offering advice to travelers who may already ... take.Over one million American businesspeople, expatriates, students studying abroad and ... offers five basic tips:, , ...
... Offers Significant Improvement - , , CHICAGO ... at the American Urological Association,s (AUA) Annual Conference show ... and sustained improvements of both irritative and obstructive urinary ... within three to four days of starting treatment. ...
... deaths are likely , , TUESDAY, April 28 (HealthDay News) -- ... United States continued to climb Tuesday, to 64, with all ... York City high school that had previously reported 18 cases ... are 64 confirmed cases in the United States in five ...
Cached Medicine News:Health News:Acrylamide Doesn't Raise Lung Cancer Risk 2Health News:Acrylamide Doesn't Raise Lung Cancer Risk 3Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 2Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 3Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 4Health News:Combating Swine Flu: HTH Worldwide Offers Tips to Travelers 2Health News:Combating Swine Flu: HTH Worldwide Offers Tips to Travelers 3Health News:Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients 2Health News:Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients 3Health News:Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients 4Health News:Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients 5Health News: U.S. Swine Flu Cases Surpass 60 2Health News: U.S. Swine Flu Cases Surpass 60 3
(Date:10/31/2014)... Ga. , Oct. 31, 2014  Digirad Corporation ... to PDI, Inc. (Nasdaq: PDII ), a ... of Digirad,s proposal to acquire the company.  ... meaningful discussions regarding a transaction and to operate in ... its cash, or take on additional debt, on acquisitions ...
(Date:10/31/2014)... 31, 2014 Mast Therapeutics, Inc. (NYSE MKT: ... for the quarter ended September 30, 2014. ... said:  "The third quarter was productive for Mast. Consistent with ... MST-188 for sickle cell disease is on track to ... have opened 50 study sites in the U.S. and ...
(Date:10/31/2014)... , October 31, 2014 ... Corporation (NASDAQ: CELG ), Bristol-Myers Squibb Co. ... UNH ), Sanofi SA (NYSE: ... members receive these notes ahead of publication. To reserve ... . , ,-- ,Celgene Corporation Research Reports ,On October ...
Breaking Medicine Technology:Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 2Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 3Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 4Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 4Mast Therapeutics Reports Third Quarter 2014 Financial Results 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 6Mast Therapeutics Reports Third Quarter 2014 Financial Results 7Mast Therapeutics Reports Third Quarter 2014 Financial Results 8Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6